Erin Wilson analyst MORGAN STANLEY

Currently out of the existing stock ratings of Erin Wilson, 3210 are a BUY (69.44%), 1051 are a HOLD (22.73%), 362 are a SELL (7.83%).

Erin Wilson

Work Performance Price Targets & Ratings Chart

Analyst Erin Wilson works at MORGAN STANLEY with a stock forecast success ratio of 73.12% fulfilled within 177.62 days on average. Previously, Erin Wilson worked at CREDIT SUISSE.

Erin Wilson’s has documented 578 price targets and ratings displayed on 29 stocks. The coverage is on Healthcare, Basic Materials, Consumer Cyclical sectors.

Most recent stock forecast was given on CVS, CVS Health Corp at 23-Nov-2022.

Wall Street Analyst Erin Wilson

Analyst best performing recommendations are on MRVI (MARAVAI LIFESCIENCES HOLDINGS ).
The best stock recommendation documented was for MRVI (MARAVAI LIFESCIENCES HOLDINGS ) at 8/11/2021. The price target of $54 was fulfilled within 1 day with a profit of $4 (8%) receiving and performance score of 80.

Average potential price target upside

ALGN Align Technology CVS CVS Health Corp HSIC Henry Schein IDXX IDEXX Laboratories PDCO Patterson Companies ELAN Elanco Animal Health AVTR Avantor CHWY Chewy CVET Covetrus DGX Quest Diagnostics orporated DHR Danaher FLGT Fulgent Genetics HSKA Heska ICLR ICON PLC IQV IQVIA Holdings MEDP Medpace Holdings NVST Envista Holdings Corp PETS PetMed Express SDC SmileDirectClub PAHC Phibro Animal Health SYNH Syneos Health TMO Thermo Fisher Scientific XRAY Dentsply Sirona ZTS Zoetis CAH Cardinal Health CRL Charles River Laboratories MCK McKesson MRVI Maravai Lifesciences Holdings  ABC AmerisourceBergen

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

335

$21.94 (7.01%)

290

28 days ago

14/26 (53.85%)

$61.62 (22.54%)

93

Hold

260

$-53.06 (-16.95%)

200

30 days ago

7/13 (53.85%)

$-4.74 (-1.79%)

146

Buy

310

$-3.06 (-0.98%)

260

1 months 10 days ago

21/27 (77.78%)

$43.66 (16.39%)

97

Hold

234

$-79.06 (-25.25%)

393

4 months 2 days ago

9/10 (90%)

$43.06 (22.55%)

217

Buy

250

$-63.06 (-20.14%)

430

4 months 3 days ago

27/34 (79.41%)

$59.44 (31.19%)

149

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Erin Wilson?

On 2014

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?